Details for New Drug Application (NDA): 207071
✉ Email this page to a colleague
The generic ingredient in FINACEA is azelaic acid. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.
Summary for 207071
Tradename: | FINACEA |
Applicant: | Leo Pharma As |
Ingredient: | azelaic acid |
Patents: | 5 |
Pharmacology for NDA: 207071
Physiological Effect | Decreased Protein Synthesis Decreased Sebaceous Gland Activity |
Suppliers and Packaging for NDA: 207071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071 | NDA | LEO Pharma Inc. | 50222-303 | 50222-303-50 | 1 CAN in 1 CARTON (50222-303-50) / 50 g in 1 CAN |
FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071 | NDA | LEO Pharma Inc. | 50222-303 | 50222-303-91 | 1 CAN in 1 CARTON (50222-303-91) / 15 g in 1 CAN |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 15% | ||||
Approval Date: | Jul 29, 2015 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Oct 18, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TOPICAL TREATMENT OF INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 18, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 1, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TOPICAL TREATMENT OF INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA |
Expired US Patents for NDA 207071
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | FINACEA | azelaic acid | AEROSOL, FOAM;TOPICAL | 207071-001 | Jul 29, 2015 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription